Company / Working Capital per Share
Corcept Therapeutics Incorporated Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$2.66
FY2025
5-year range
$2.07 / $3.96
FY2021-FY2025
Trend
-15.4%
vs FY2024
Sector context
#151 of 210
Health Care
What the data says
At $2.66, Corcept Therapeutics Incorporated's working capital per share ranks #151 of 210 in the Health Care sector. Working Capital per Share has declined for 3 consecutive years, from $3.96 in FY2022 to $2.66 in FY2025.
Based on SEC 10-K filings.
2.66 in FY2025 with a 5-year CAGR of -6.3%.
Declined from $3.42 to $2.66 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -12.4%
- 5-Year CAGR
- -6.3%
- 10-Year CAGR
- -
Sector benchmark
#151 of 210 in Health CareTop 72% of 210This company $2.66 Sector average $146.71
▼
-98.2% below sector average
Key checks
Key Insights
- Corcept Therapeutics Incorporated's working capital per share has declined for 3 consecutive years.
- In FY2025, working capital per share decreased 15.4% year-over-year.
- Ranks #151 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.66 | -15.4% |
| FY2024 | $3.15 | -8.1% |
| FY2023 | $3.42 | -13.5% |
| FY2022 | $3.96 | +91.5% |
| FY2021 | $2.07 | -44.0% |
| FY2020 | $3.69 | +58.2% |
| FY2019 | $2.33 | +33.1% |
| FY2018 | $1.75 | +109.0% |
| FY2017 | $0.84 | +140.2% |
| FY2016 | $0.35 | +26.1% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026